URETER UROTHELIAL CARCINOMA
Clinical trials for URETER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new URETER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for URETER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug duo tested before surgery for tough bladder cancers
Disease control OngoingThis early-stage study is testing the safety of a two-drug immunotherapy combination (durvalumab and tremelimumab) given before surgery to patients with aggressive bladder and related urinary tract cancers. The trial is specifically for patients who cannot receive the usual pre-s…
Matched conditions: URETER UROTHELIAL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC